| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |